A large Arizona-based infusion provider with 19 outpatient centers and physician practice partnerships offers therapy for complex chronic conditions through both clinic-based and fully managed practice models.
A large Arizona-based infusion provider with 19 outpatient centers and physician practice partnerships offers therapy for complex chronic conditions through both clinic-based and fully managed practice models.
For HME providers, revenue cycle management (RCM) is not just about billing - it is the foundation of financial health.
Not all denials deserve equal attention. In fact, 50% of claims often represent more than 99% of payments. The fastest way to reduce A/R pressure is to group denials by payer and denial code, then work them strategically.
Prochant is proud to announce that it has been named to the 2025 Inc. 5000 list of fastest-growing private companies in the U.S. for the fifth year in a row, a rare distinction among honorees.
The U.S. home-based care industry is closely watching proposed changes to pharmaceutical trade policy that could have significant downstream effects on operations and reimbursement.
In this episode, the hosts explore a topic that’s becoming impossible to ignore across the infusion therapy landscape: the escalating talent crisis.
In today’s challenging home medical equipment (HME) landscape, delivering financial performance requires more than just keeping up. It demands a proactive, strategic approach to revenue cycle management. That’s why Prochant’s CEO Joey Graham and NuCara Home Medical’s CEO Matthew Flatt are teaming up for a results-driven conversation that reveals how top-performing HME providers are transforming operations and achieving real outcomes.
For HME providers, revenue cycle management is more than a billing function. It plays a central role in financial stability, operational efficiency and long-term growth. Yet many providers are losing revenue every day due to inefficiencies that often go unnoticed.
The landscape for home medical equipment (HME) providers is shifting rapidly. With new legislation and regulatory proposals on the horizon, 2025 is proving to be a defining year for reimbursement, compliance and operational sustainability.
The Prochant team was thrilled to attend the 2025 NICA Annual Conference, held June 20–21 in Miami, Florida. Represented by Lee Pratt, Gabby Whitmire and Jason Dillon, we spent two energizing days engaging with infusion pharmacy professionals from across the country and walked away with fresh insights and new connections.
